Article ID Journal Published Year Pages File Type
3999909 Urologic Oncology: Seminars and Original Investigations 2013 7 Pages PDF
Abstract
Prognosis in UCB staged pT4a is heterogeneous. Female gender and LVI are adverse factors. Adjuvant chemotherapy seems to improve outcome. The present analysis establishes the first risk model for this demanding tumor stage.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , , , , , , , , , , , ,